ODI Pharma AB

ODI Pharma is a producer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales are made through wholesale distributors and pharmacies. The products are used for the treatment of, for example, multiple sclerosis, chronic pain and chemotherapy. Operations are found within the European market, with the headquarters in Stockholm.

Quotes for ODI Pharma AB

Right Now

+/-
-0.49
%
−24,75%
Latest
1.49
High
1.7
Low
1.43
Volume
54 414
Turnover (SEK)
85 030
Market Value (MSEK)
27,3
Time (Latest trade)

Board

CEO

  • Jan-Mark Edewaard

Chairperson of the Board

  • Volker Wiederrich

Board

  • Gösta Lidén
  • Jan-Mark Edewaard
  • Karina Kilinski
  • Malcolm Allan
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    ODI Pharma AB - Company presentation

    Largest Owners

    Name Capital % Votes % Date
    Volker Wiederrich 38,53 38,53 2025-06-26
    Niclas Kappelin 29,37 29,37 2025-06-26
    Derek Simmross 23,23 23,23 2025-06-26
    Jan-Mark Edewaard 1,85 1,85 2025-06-26
    Tomi Kalevi Heikkinen 0,27 0,27 2025-06-26
    Carl Fredrik Christoffer Clementson 0,25 0,25 2025-06-26
    Avanza Pension 0,17 0,17 2025-06-26
    Per Herseth 0,13 0,13 2025-06-26
    Nordnet Pensionsförsäkring 0,12 0,12 2025-06-26
    Robert Bergström 0,10 0,10 2025-06-26
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2025-08-28 Bokslutskommuniké 2025

    Annual reports, prospectus etc.